KemPharm Q3 EPS $0.06 Beats $(0.19) Estimate, Sales $11.56M Beat $2.93M Estimate

KemPharm (NASDAQ:KMPH) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.19) by 131.58 percent. This is a 106.38 percent increase over losses of $(0.94) per share from the

Benzinga · 11/14/2019 21:56

KemPharm (NASDAQ:KMPH) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.19) by 131.58 percent. This is a 106.38 percent increase over losses of $(0.94) per share from the same period last year. The company reported quarterly sales of $11.56 million which beat the analyst consensus estimate of $2.93 million by 294.54 percent.